Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

NETWORK 2 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 552 Colorectal Neoplasms 246 Neoplasms 232 Prostatic Neoplasms 221 Carcinoma, Non-Small-Cell Lung 196 Stomach Neoplasms 153 Leukemia, Myeloid, Acute 149 Carcinoma, Hepatocellular 147 Lung Neoplasms 137 Rectal Neoplasms 135 Multiple Myeloma 133 Nasopharyngeal Carcinoma 112 Colonic Neoplasms 106 Neoplasm Metastasis 100 Precursor Cell Lymphoblastic Leukemia-Lymphoma 86 Lymphoma 85 Uterine Cervical Neoplasms 83 Pancreatic Neoplasms 82 Lymphoma, Large B-Cell, Diffuse 79 Ovarian Neoplasms 78 Leukemia 78 Head and Neck Neoplasms 77 Esophageal Neoplasms 74 Lymphoma, Follicular 72 Brain Neoplasms 70 Squamous Cell Carcinoma of Head and Neck 65 Recurrence 64 Leukemia, Lymphocytic, Chronic, B-Cell 59 Lymphoma, Non-Hodgkin 58 Pain 56

Interventions

Idarubicin 1 Etoposide 1 Daunorubicin 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Down Syndrome × Clear all

NCT07232134 2025-11-20

AML-DS-2025

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Other hematologic neoplasm

Down Syndrome, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡